Ana García-Fulgueiras* , Carmen Navarro*, Daniel Fenoll†, José García*, Paulino González-Diego*, Teresa Jiménez-Buñuales*, Miguel Rodriguez*, Rosa Lopez*, Francisco Pacheco*, Joaquín Ruiz‡, Manuel Segovia§, Beatriz Baladrón¶, and Carmen Pelaz¶
Author affiliations: *Regional Health Council of Murcia, Murcia, Spain; †Council of Murcia, Murcia, Spain; ‡Virgen de la Arrixaca Hospital, Murcia, Spain; §Morales Meseguer Hospital, Murcia, Spain; ¶Health Institute of Carlos III, Madrid, Spain
Figure 4. Amplified fragment length polymorphism (AFLP) gel containing outbreak human and environmental Legionella pneumophila serogroup 1 isolates. M, molecular weight marker (Ladder Mix, MBI Fermentas, UK). Lanes 1 and 2, two colonies from a cooling tower of the hospital H. Lines 3 and 4, human isolates. Lanes 5 and 6, human isolates. Lanes 7–11, different environmental isolates from several Murcia installations.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.